Jubb AM - Search Results

1

Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer.

Herbst RS, Eckhardt SG, Kurzrock R, Ebbinghaus S, O'Dwyer PJ, Gordon MS, Novotny W, Goldwasser MA, Tohnya TM, Lum BL, Ashkenazi A, Jubb AM, Mendelson DS. Herbst RS, et al. Among authors: jubb am. J Clin Oncol. 2010 Jun 10;28(17):2839-46. doi: 10.1200/JCO.2009.25.1991. Epub 2010 May 10. J Clin Oncol. 2010. PMID: 20458040 Clinical Trial.

2

Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer.

Jubb AM, Hurwitz HI, Bai W, Holmgren EB, Tobin P, Guerrero AS, Kabbinavar F, Holden SN, Novotny WF, Frantz GD, Hillan KJ, Koeppen H. Jubb AM, et al. J Clin Oncol. 2006 Jan 10;24(2):217-27. doi: 10.1200/JCO.2005.01.5388. Epub 2005 Dec 19. J Clin Oncol. 2006. PMID: 16365183 Clinical Trial.

3

MET Suppresses Epithelial VEGFR2 via Intracrine VEGF-induced Endoplasmic Reticulum-associated Degradation.

Chen TT, Filvaroff E, Peng J, Marsters S, Jubb A, Koeppen H, Merchant M, Ashkenazi A. Chen TT, et al. EBioMedicine. 2015 Mar 28;2(5):406-20. doi: 10.1016/j.ebiom.2015.03.021. eCollection 2015 May. EBioMedicine. 2015. PMID: 26137585 Free PMC article.

4

Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab.

Ince WL, Jubb AM, Holden SN, Holmgren EB, Tobin P, Sridhar M, Hurwitz HI, Kabbinavar F, Novotny WF, Hillan KJ, Koeppen H. Ince WL, et al. Among authors: jubb am. J Natl Cancer Inst. 2005 Jul 6;97(13):981-9. doi: 10.1093/jnci/dji174. J Natl Cancer Inst. 2005. PMID: 15998951

5

EphB2 is a prognostic factor in colorectal cancer.

Jubb AM, Zhong F, Bheddah S, Grabsch HI, Frantz GD, Mueller W, Kavi V, Quirke P, Polakis P, Koeppen H. Jubb AM, et al. Clin Cancer Res. 2005 Jul 15;11(14):5181-7. doi: 10.1158/1078-0432.CCR-05-0143. Clin Cancer Res. 2005. PMID: 16033834

6

Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours.

Jubb AM, Pham TQ, Hanby AM, Frantz GD, Peale FV, Wu TD, Koeppen HW, Hillan KJ. Jubb AM, et al. J Clin Pathol. 2004 May;57(5):504-12. doi: 10.1136/jcp.2003.012963. J Clin Pathol. 2004. PMID: 15113858 Free PMC article.

7

Predicting benefit from anti-angiogenic agents in malignancy.

Jubb AM, Oates AJ, Holden S, Koeppen H. Jubb AM, et al. Nat Rev Cancer. 2006 Aug;6(8):626-35. doi: 10.1038/nrc1946. Epub 2006 Jul 13. Nat Rev Cancer. 2006. PMID: 16837971 Review.

8

Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer.

Jubb AM, Miller KD, Rugo HS, Harris AL, Chen D, Reimann JD, Cobleigh MA, Schmidt M, Langmuir VK, Hillan KJ, Chen DS, Koeppen H. Jubb AM, et al. Clin Cancer Res. 2011 Jan 15;17(2):372-81. doi: 10.1158/1078-0432.CCR-10-1791. Epub 2011 Jan 11. Clin Cancer Res. 2011. PMID: 21224365 Free PMC article.

9

Neuropilin-1 expression in cancer and development.

Jubb AM, Strickland LA, Liu SD, Mak J, Schmidt M, Koeppen H. Jubb AM, et al. J Pathol. 2012 Jan;226(1):50-60. doi: 10.1002/path.2989. Epub 2011 Oct 25. J Pathol. 2012. PMID: 22025255

10

Plasmalemmal vesicle-associated protein (PLVAP) is expressed by tumour endothelium and is upregulated by vascular endothelial growth factor-A (VEGF).

Strickland LA, Jubb AM, Hongo JA, Zhong F, Burwick J, Fu L, Frantz GD, Koeppen H. Strickland LA, et al. Among authors: jubb am. J Pathol. 2005 Aug;206(4):466-75. doi: 10.1002/path.1805. J Pathol. 2005. PMID: 15971170

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page